Connor, Clark & Lunn Investment Management Ltd. Moderna, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$85.37 - $115.44 $196,351 - $265,512	2,300 New	2,300 $245,000
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $959,060 - $1.45 Million	-8,188 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $11.7 Million - $21.7 Million	-92,153 Reduced 91.84%	8,188 $1.41 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $15.5 Million - $25.3 Million	-68,562 Reduced 40.59%	100,341 $25.5 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $15.4 Million - $33.6 Million	-69,255 Reduced 29.08%	168,903 $65 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $13.4 Million - $24.2 Million	-102,939 Reduced 30.18%	238,158 $56 Million
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $28 Million - $47.7 Million	256,641 Added 303.88%	341,097 $44.7 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $1.38 Million - $3.58 Million	21,048 Added 33.19%	84,456 $8.82 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $1.35 Million - $2.35 Million	24,801 Added 64.24%	63,408 $4.49 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $1.15 Million - $3.09 Million	38,607 New	38,607 $2.48 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account